Analytical Data
-
基因名
MAGEB10
- Application
-
别名
SUOX;Sulfite oxidase. mitochondrial
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96LZ2
-
表达区间
1-347aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMGSMPRGQKSKLRAREKRRQARGGLEDLID ALDILEEEEESPPSASACLKDVFQSSLDGASNNPHGLREAQSTSTSATAA SHTRHPEGVNDQMEERPICTQDLEATDSFP RGPVDEKVIILVHYLLYKYQMKEPITKADMLRNVTQMSKSQFPVILSRAS EHLELIFGLDLKEVEPNKHIYVLVNKLDLGCDAKLSDETGVPKTGLLMTV LGIIFTNGNCVAEEEVWKVFNTMGLYDGIEHFMFGEPRKLLTKDLVKENY LEYQQVPNSDPPRYQFLWGPRAHAETSKMKVLEFLAKVNDTAPSEFSNWY TEALQDEEERARARVAAKAR VSATAGARSKVKSSKSSQLQ
-
分子量
41 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human KLHL21 Protein，GST
Cat：PA2000-8749
Recombinant Human MAGEA8 Protein，His
Cat：PA1000-1877
Protein Description
MAGEB10 (Melanoma Antigen Gene B10) is a member of the MAGE family of genes, which are known for their roles in tumor immunology and cancer biology. Primarily expressed in the testis and various tumor tissues, MAGEB10 encodes a protein that is considered a promising target for cancer immunotherapy due to its immunogenic potential. The study of MAGEB10 and its recombinant protein has garnered significant interest in recent years, as it may elicit strong immune responses in cancer patients, making it a candidate for therapeutic vaccine development. Researchers have been exploring its expression patterns, functional roles in tumor progression, and potential utility in diagnostic and prognostic applications. By understanding the molecular mechanisms underlying MAGEB10's involvement in oncogenesis, scientists aim to leverage this knowledge to improve treatment strategies, specifically in melanoma and other malignancies. The development of MAGEB10-based recombinant proteins could lead to novel immunotherapeutic approaches, enhancing the immune system's ability to recognize and combat cancer cells effectively. Overall, the study of MAGEB10 represents a convergence of cancer biology, immunology, and biotechnology, with the potential to significantly impact cancer treatment paradigms.
